Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis.
Kontoyiannis
Dimitrios P
DP
D000666:Amphotericin B / Q000494:pharmacology; D000935:Antifungal Agents / Q000009:adverse effects* / Q000494:pharmacology; D001232:Aspergillus fumigatus / Q000187:drug effects; D004352:Drug Resistance, Microbial; D015725:Fluconazole / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D009181:Mycoses / Q000209:etiology* / Q000382:microbiology; D009894:Opportunistic Infections / Q000209:etiology / Q000382:microbiology; D012307:Risk Factors
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole